Holen Sie sich die Stockscreener-App
42.60
1.31%
0.55
Finanzdaten der Vera Therapeutics Inc-Aktie (VERA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
15.11%
31.11
|
27.03 | 21.76 | 21.97 | 31.26 |
| Interest Income/Expense |
80.49%
1.906
|
1.056 | 0.943 | 0.914 | 0.874 |
| Operating Income/Loss |
15.11%
-31.11
|
-27.03 | -21.76 | -21.97 | -31.26 |
| Nonoperating Income/Loss |
98.62%
2.729
|
1.374 | 1.652 | 1.808 | 1.189 |
| Income/Loss From Continuing Operations Before Tax |
10.64%
-28.38
|
-25.65 | -20.10 | -20.16 | -30.07 |
| Income/Loss From Continuing Operations After Tax |
10.63%
-28.38
|
-25.66 | -20.10 | -20.16 | -30.07 |
|
Net Income/Loss
|
10.63%
-28.38
|
-25.66 | -20.10 | -20.16 | -30.07 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
8,654%
50.97
|
0.5823 | 44.36 | 44.27 | 37.67 |
| Diluted Average Shares |
8,654%
50.97
|
0.5823 | 44.36 | 44.27 | 37.67 |
| Basic Earnings Per Share |
3.45%
-0.56
|
-0.58 | -0.45 | -0.46 | -0.80 |
| Diluted Earnings Per Share |
3.45%
-0.56
|
-0.58 | -0.45 | -0.46 | -0.80 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
2.88%
2.65%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):